Skip to content

Effect of Anti-inflammatory Diet in Rheumatoid Arthritis

An Evaluator-blinded Randomized Controlled Trial Study of the Effect of Anti-inflammatory Diet in Subjects With Rheumatoid Arthritis.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04748809
Enrollment
124
Registered
2021-02-10
Start date
2020-11-01
Completion date
2026-03-01
Last updated
2026-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

In a previous exploratory study, the investigators observed an effect on disease activity outcomes of anti-inflammatory diet. The investigators also observed change in microbiome and circulating metabolites. The current study will determine whether or not the addition of anti-inflammatory diet improves the clinical outcomes in participants with rheumatoid arthritis, and the role of microbiome and circulating metabolites.

Interventions

OTHERDiet 1

Dietary intervention

OTHERDiet 2

Dietary intervention

Sponsors

University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with low or moderate disease activity (defined as Clinical Disease Activity Index ≤ 22) and without changes in disease activity or therapy during the previous 3 months, who are interested in dietary intervention, and are able to provide consent and attend to follow up visits.

Exclusion criteria

* Pregnancy or lactating. Patients that will become pregnant during the study will be remove from the study. * Food allergies * Subjects with significant other comorbidities and /or medication use which in physician's clinical judgment might difficult the interpretation of the results

Design outcomes

Primary

MeasureTime frame
Decrease of more than 5 points in Clinical Disease Activity Index3 months

Countries

United States

Contacts

Primary ContactMonica Guma, MD, PhD
mguma@health.ucsd.edu8588226523

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026